In Medicine, is the Professor Necessary in View of the Wonderful Online Information?

Main Article Content

José F Guadalajara-Boo, MD

Abstract

Advances in technology and the media have favored that knowledge can be obtained quickly and completely for all sciences; so, students can get information in this way; now you can complete professional careers "online", therefore. Is the presence of a professor necessary to study medicine and specialties?


In this paper, the forms of learning at the different levels of professional training, objective learning (learning they should know), the objectives pursued with learning, the role of culture and humanism in medicine are analyzed; they must learn the study of the  techniques of evidence-based medicine and the clinical guidelines. The exam preparation courses, the objectives of how the learning of medical education should be structured are analyzed; how the medical attitude towards the patient should be individualized, what role does the clinical judgment play in the doctor, the terminal efficiency, all this in the university career of medicine and specialties in tertiary hospitals and in conclusion: The physical presence of the expert professor is important to carry out a tutorial teaching with direction in the academic and ethical evolution of the doctor in training throughout his career, in order to achieve an excellent clinical doctor who dominates the wonderful modern technology that he uses.

Article Details

How to Cite
GUADALAJARA-BOO, José F. In Medicine, is the Professor Necessary in View of the Wonderful Online Information?. Medical Research Archives, [S.l.], v. 10, n. 8, aug. 2022. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3045>. Date accessed: 07 oct. 2022. doi: https://doi.org/10.18103/mra.v10i8.3045.
Section
Research Articles

References

1. Guadalajara-Boo JF. La imagen del profesor. In: Libro “Homenaje del Dr. Octavio Rivero Serrano 50 años de vida académica” 1958-2008, Universidad Nacional Autónoma de México, Facultad de Medicina, pag. 67-69.
2. Guadalajara-Boo JF. Prologo. In: Tratado de terapéutica intensiva cardiovascular. Un enfoque multidisciplinario. Editor en Jefe Dr. Francisco Martín Baranda, Edit. Distribuna. ISBN 978-958-8813-88-2, México, 2019.
3. Jaime Martín-Mendoza, El perfil del estudiante de Medicina. In: Vol. 2 No. 2, enero-feb. 1997, pág. 7. Boletín informativo de los alumnos de la Facultad de Medicina Dr. Ignacio Chávez, Universidad Michoacana, San Nicolás de Hidalgo, No. Especial en el Centenario del Natalicio del Dr. Ignacio Chávez.
4. Ignacio Chávez, La actitud del estudiante universitario ante el país. (Conferencia en Toluca 10 de junio 1962). In: Humanismo Medico Educación y Cultura. Edit. El Colegio Nacional, 1985, pág. 171
5. Ignacio Chávez. Ciencia, técnica y humanismo en la formación de los cardiólogos del mañana. Conferencia sustentada en Washington en la Ceremonia del XVIII Aniversario del American College of Cardiology, Feb. 1967. In: Humanismo Médico Educación y Cultura, 1978. Pág. 54.
6. Ignacio Chávez. Deberes y responsabilidades del médico de hoy frente al futuro. (Conferencia sustentada en la Facultad de Medicina de San Luis Potosí, julio, 1975). In: Humanismo Médico Educación y Cultura, 1978, págs. 73-74
7. Ignacio Chávez. Grandeza y miseria de la especialización médica, aspiración a un nuevo humanismo. In: Humanismo Médico, Educación y Cultura. Ed. Colegio Nacional, 1978, pág. 33.
8. Guadalajara-Boo José F. Understanding Heart Failure. J Cardiovasc Res. 2016;6:1-8.
9. Trevethan-Cravioto S. La clínica la madre de todos los instrumentos. Ed. Revista de Investigación Clínica. 2011;63:223-26.
10. Guadalajara-Boo J.F. La auscultación del corazón, un arte en vías de extinción. Gac Med Méx. 2015;151:260-5.
11. Ramos-Lara, M.P., Masilla-Corona, R., Mendoza-Rosas, R.M. Arturo Rosenblueth Stern en el Instituto Nacional de Cardiología Ignacio Chávez. In Book: Arturo Rosenblueth: legado y vigencia de sus contribuciones. Eds. Universidad Nacional Autónoma de México e Instituto Nacional de Cardiología “Ignacio Chávez”, México 2019, pág. 174.
12. Ghali JK, Massie BM, Mann DL, Rich MW. Heart Failure Guidelines, Performance Measures and the Practice of Medicine. Mind the Gap. J Am Coll Cardiol. 2010;56:2077-80.
13. Lloid-Jones DM, Mark D. H, Kasmali KN, Sanghavi DM, Wright JS, Pelser C, Gulati M, et al. Estimating longitudinal risk and benefits from cardiovascular preventive therapies omang medicare patients the million heart longitudinal ASCVD Risk assessment tool. A special report from AMH and ACC. J Am Coll Cardiol. 2017;69:1617-36.
14. C Baigent, A Keech, P M Kearney, L Blackwell, G Buck, C Pollicino, A Kirby, T Sourjina, R Peto, R Collins, R Simes and Collaborators. Cholesterol treatment trialest (CTT) colaborators. Efficacy and safety of cholesterol lowering treatment: prospective Meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
15. Hissh BJ, Sniolowitz NR, Rosenson RS, Fuster V., Sperling LS. Utilization of and adherence to guideline-recommended lipid lowering therapy after acute coronary syndrome: opportunities for improvement. J Am Coll Cardiol. 2015;66:184-92.
16. Nissen SE, Nicholls SJ, Sipahi L, Libby P, Raichlen JS, Ballantyne CM, et al. Effect high-intensity status therapy on regression of coronary atherosclerosis “The ASTEROID trial”. JAMA. 2006;295:1556-65.
17. Pfeffer MD, Braunwald E., Mayé LA, Basta L, Brown EJ, Cuddy R, et al. The effects of captopril on mortality left ventricular dysfunction following myocardial infarction Result of the survival and ventricular enlargement “SAVE Trial”. N Engl J Med. 1992;327:669-77.
18. Packer M, Fowler MB, Roecker EB, Coats JS, Katus HA, Krum DJ, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-58.
19. Gheorghiade M, Patel K, Filippatos GI, Anker SD, Van Beldhuisen DJ, Cleland JGB, et al. Effect of oral digoxin in high risk heart failure patients; pre-specified subgroup analysis of the DIG trial. Eur J Heart Fail. 2013;15:551-59.
20. The Digitalis Investigation Group. The effect of the digoxin on mortality and morbidity in patients whit heart failure. N Engl J Med. 1997;336:525-33.
21. Gheorghiade M, Braunwald E. Reconsidering the role for digoxin in the management of acute Heart Failure Syndromes. JAMA 2009;302:2146-7.
22. Ignacio Chávez. Los rápidos avances de la Medicina y la lenta implacable deshumanización de la medicina. Caracas, Venezuela sept. 9, 1976. Educación, Medicina y Cultura. Ed. El Colegio Nacional. Pag. 87.